A Rare but Lethal Malignant Cardiac Mass

Michael Cruz Caliz, Ivan Gonzalez-Cancel, Ricardo Fernandez, Modesto Gonzalez, Gustavo Gonzalez, Kelvin Rivera-Manzano

Abstract


Primary cardiac tumors are extremely rare. Incidence is approximately 0.017% of all primary tumors. Spindle cell sarcoma is the rarest, with only four cases reported and there are no guidelines for treating this condition. Cardiac sarcomas have symptoms by different mechanisms including obstruction, local invasion, and embolisms and in some cases the first manifestation could be a sudden cardiac death. Diagnosis is made with imaging techniques such as echocardiogram, cardiac computed tomography (CT), and magnetic resonance imaging (MRI) and confirmed with tissue biopsy. Patients with malignant tumors have a poor prognosis with an average mean survival of 6 months. Complete resection of the tumor remains the best treatment available. Spindle cell sarcoma may present with few symptoms and may remain silent until an advanced stage, thus limiting the few therapeutic options available.




J Med Cases. 2016;7(11):498-501
doi: http://dx.doi.org/10.14740/jmc2663w


Keywords


Cardiac tumor; Spindle cell sarcoma; Cardiac sarcoma; Cardiac mass

Full Text: HTML PDF
 

Browse  Journals

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.